NUUU — Rejuvel Bio-Sciences Income Statement
0.000.00%
Last trade - 00:00
Consumer CyclicalsHighly SpeculativeMicro Cap
- $0.00m
- $0.36m
- $0.09m
2010 December 31st | 2011 December 31st | 2012 December 31st | 2013 December 31st | 2014 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.002 | 0.008 | 0.052 | 0.094 |
Cost of Revenue | |||||
Gross Profit | — | 0.001 | 0.004 | 0.025 | 0.011 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.025 | 0.229 | 0.686 | 0.58 | 0.781 |
Operating Profit | -0.025 | -0.228 | -0.678 | -0.529 | -0.687 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.025 | -0.228 | -0.834 | -0.716 | -0.353 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.025 | -0.228 | -0.834 | -0.716 | -0.353 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.025 | -0.228 | -0.834 | -0.716 | -0.353 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.025 | -0.228 | -0.834 | -0.716 | -0.353 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.008 | -0.009 | -0.007 | -0.006 | -0.004 |
Dividends per Share |